Clinical Trials · NCT04804267

Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation

UnknownPhase 3Linaclotide (Unclear)
Phase
Phase 3
Recruitment status
Unknown
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Enrollment
750
Start date
Mar 2021
Locations
1 site, China
Primary endpoint
The number of spontaneous bowel movements (SBM) during Week 1
View Linaclotide compound reference